TGA
Tenecteplase shortage to continue
Boehringer Ingelheim has notified the TGA that its tenecteplase shortage will continue until the end of next year In August 2022, BI had told the Therapeutic Goods Administration that the …
Liver injury warning
The TGA has warned consumers and health professionals that turmeric and curcumin-containing medicines and supplements may pose a liver risk Medicines and herbal supplements containing the herb Curcuma longa (turmeric) …
Somatropin stocks hit on two fronts
One version of the synthetic growth hormone in short supply while another is discontinued The somatropin products marketed as Norditropin FlexPro 5mg, 10mg and 15mg will be in shortage until …
$91.5k in fines for alleged medical cannabis advertising
TGA hits cannabis clinic Trava Health and “an individual” in latest crackdown The Therapeutic Goods Administration (TGA) has issued infringement notices to Melbourne-based medicinal cannabis clinic Trava Health for alleged …
Tightening the screws
TGA says it will clamp down on vapes, medicinal cannabis and the wellness industry over the next 12 months The Therapeutic Goods Administration (TGA) has published its import, advertising and supply …
TGA hits vaping outfit/director with $106k in fines
Nature’s Puff latest to fall foul of Govt vaping crackdown Eight infringement notices totalling $105,600 have been issued to trans-Tasman operation Nature’s Puff Pty Ltd and one of its directors …
Regulator investigates Ozempic suicidal ideation link
Novo Nordisk’s diabetes medication, Ozempic (semaglutide) and weight-loss treatment Saxenda (liraglutide) are being investigated, following reports they may be associated with suicidal ideation The European Medicines Agency (EMA) is looking …
Palliative care groups sound alarm on drug drought
Concerns grow over discontinuation of “gold standard” pain relief brand Ordine from later this year A group of 18 palliative care organisations led by Palliative Care Australia is calling for …
Extension to Covid medicine PBS listing
Government announces a new demographic cohort will have PBS access to an anti-COVID medication The Federal government has announced that, from 1 July, the eligibility criteria for PBS access to …
Ozempic shortage pain to continue until year’s end
TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to …
Ordine to be discontinued
The Therapeutic Goods Administration has provided advice regarding the discontinuation of all Ordine oral liquid medicines in Australia Mundipharma has advised that it will discontinue all four strengths of its …
Skerritt’s successor slips in unannounced
Professor Tony Lawler was formerly CMO with Tasmanian health department The new head of the Therapeutic Goods Administration has made his way into the role with not even an announcement …